首页|期刊导航|mLife|Rapid and quantitative phage susceptibility test by ramanome

Rapid and quantitative phage susceptibility test by ramanomeOA

中文摘要

Antimicrobial resistance poses an escalating global threat,renewing interest in bacteriophage therapy as a precision alternative to antibiotics.However,clinical translation remains hindered by the lack of rapid and quantitative phage susceptibility testing(PST)platforms capable of evaluating host range,infection potency,and effective multiplicity of infection(MOl).Here,we present a ramanome-based phage susceptibility test(RPST),a phenotypic platform that captures infection-induced remodeling of bacterial macromolecular composition to unify these diagnostic requirements within a single workflow.RPsT integrates four Raman biomarkers into a Composite Infection Index(CII),enabling rapid and Iysis-independent discrimination between susceptible and resistant bacterial populations within~1 h,with 96.0% categorical concordance(24/25)to plaque assays.As a continuous population-level metric,CII quantifies the proportion of infected cells,allowing quantitative ranking of phage potency against shared hosts.By resolving CII trajectories across the MOI and time,RPST further determines the minimal effective MOI,which is the lowest phage-to-bacterium ratio sustaining self-propagating infection,thereby defining the lower boundary for therapeutic feasibility.Together,these capabilities transform PST from static compatibility assays into a dynamic and quantitative framework that bridges in vitro infectivity assessment and infection dynamics relevant to phage therapy.

Xiao Han;Xiaofu Wan;Yang Zhou;Xiaoting Fu;Xiaoshan Zheng;Bo Gao;Shi Huang;Anle Ge;Jiadong Huang;Hongzhou Lu;Jian Xu

School of Chemistry and Chemical Engineering,University of Jinan,Jinan,China Single-Cell Center,Shandong Energy Institute,Qingdao New Energy Shandong Laboratory,Qingdao Institute of Bioenergy and Bioprocess Technology,Chinese Academy of Sciences,Qingdao,ChinaNational Clinical Research Center for Infectious Diseases,Shenzhen Clinical Medical Research Center for Tuberculosis,Shenzhen Third People's Hospital,Southern University of Science and Technology,Shenzhen,ChinaNational Clinical Research Center for Infectious Diseases,Shenzhen Clinical Medical Research Center for Tuberculosis,Shenzhen Third People's Hospital,Southern University of Science and Technology,Shenzhen,China Molecular Biology Research Center&Center for Medical Genetics,School of Life Sciences,Central South University,Changsha,ChinaSingle-Cell Center,Shandong Energy Institute,Qingdao New Energy Shandong Laboratory,Qingdao Institute of Bioenergy and Bioprocess Technology,Chinese Academy of Sciences,Qingdao,ChinaSingle-Cell Center,Shandong Energy Institute,Qingdao New Energy Shandong Laboratory,Qingdao Institute of Bioenergy and Bioprocess Technology,Chinese Academy of Sciences,Qingdao,China University of Chinese Academy of Sciences,Beijing,ChinaSingle-Cell Center,Shandong Energy Institute,Qingdao New Energy Shandong Laboratory,Qingdao Institute of Bioenergy and Bioprocess Technology,Chinese Academy of Sciences,Qingdao,China Single-Cell Biotechnology Ltd.,Qingdao,ChinaFaculty of Dentistry,University of Hong Kong,Hong Kong,ChinaSingle-Cell Center,Shandong Energy Institute,Qingdao New Energy Shandong Laboratory,Qingdao Institute of Bioenergy and Bioprocess Technology,Chinese Academy of Sciences,Qingdao,China University of Chinese Academy of Sciences,Beijing,ChinaSchool of Life Sciences,University of Jinan,Jinan,ChinaNational Clinical Research Center for Infectious Diseases,Shenzhen Clinical Medical Research Center for Tuberculosis,Shenzhen Third People's Hospital,Southern University of Science and Technology,Shenzhen,ChinaSingle-Cell Center,Shandong Energy Institute,Qingdao New Energy Shandong Laboratory,Qingdao Institute of Bioenergy and Bioprocess Technology,Chinese Academy of Sciences,Qingdao,China University of Chinese Academy of Sciences,Beijing,China

医药卫生

antimicrobial resistance(AMR)biomarker discoveryphage susceptibility test(PST)precision phage therapyramanome

《mLife》 2026 (3)

P.369-382,14

supported by the National Natural Science Foundation of China(Nos.32030003 and 32571695)the Young Scientists in Basic Research Program from the Chinese Academy of Sciences(No.YSBR-111).

10.1002/mlf2.70089

评论